XXII 22nd Century Group, Inc.
Cigarettes · Nasdaq · SEC CIK 1347858 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-15.5%
TTM net income YoY-79.5%
TTM EPS YoY135.6%
Revenue 3-yr CAGR-24.0%
Net income 3-yr CAGR—
Margins
Gross margin53.6%
Operating margin-76.7%
Net margin-80.0%
FCF margin-43.3%
EBITDA margin-73.7%
Returns
ROE-70.9%
ROA-43.8%
ROIC (approx.)-72.0%
Asset turnover0.55x
Leverage & solvency
Liabilities / assets31.2%
Debt / equity0.00x
Current ratio2.27x
Interest coverage-205.44x
Cash quality & payout
Operating cash flow / net income0.48x
Accruals ratio-22.7%
Payout ratio—
Capex / revenue4.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $17.59M | $24.38M | $32.20M | $40.50M | $30.95M |
| Cost of revenue | $10.19M | $14.28M | $24.89M | $38.65M | $29.46M |
| Gross profit | $7.40M | $10.10M | $7.31M | $1.85M | $1.49M |
| R&D expense | $688,000 | $1.13M | $2.64M | $3.58M | $3.91M |
| SG&A expense | $7.59M | $10.29M | $31.06M | $32.23M | $25.91M |
| Operating income | -$11.57M | -$13.95M | -$44.93M | -$33.63M | -$28.41M |
| Interest expense | $1.46M | $2.09M | $9.37M | $55,000 | $58,000 |
| Pretax income | -$13.14M | -$15.46M | -$54.64M | -$36.53M | -$32.59M |
| Income tax | -$28,000 | $30,000 | $47,000 | $21,000 | $14,000 |
| Net income | -$5.05M | -$15.16M | -$140.78M | -$59.80M | -$32.61M |
| EBITDA | -$11.09M | -$13.37M | -$44.08M | -$32.96M | -$27.16M |
| EPS (basic) | -52.87 | -45,711.05 | -15,925.99 | -4.65 | -0.21 |
| EPS (diluted) | -52.87 | -45,711.05 | -15,925.99 | -4.65 | -0.21 |
| Weighted avg. shares (diluted) | 184,067 | 557 | 9,467 | 12.86M | 156.21M |
| Balance sheet | |||||
| Cash & equivalents | $7.15M | $4.42M | $2.06M | $3.02M | $1.34M |
| Short-term investments | — | — | — | $18.19M | $47.40M |
| Receivables | $3.59M | $1.70M | $1.67M | $1.36M | $585,000 |
| Inventory | $4.33M | $2.02M | $4.35M | $7.27M | $2.88M |
| Current assets | $17.63M | $11.52M | $16.28M | $44.60M | $54.38M |
| PP&E, net | $2.44M | $2.77M | $3.39M | $3.69M | $5.84M |
| Goodwill | — | — | $0 | $33.16M | $0 |
| Intangibles | $6.22M | $5.72M | $5.92M | $7.21M | $7.92M |
| Total assets | $27.02M | $21.67M | $27.50M | $114.65M | $75.95M |
| Current liabilities | $7.27M | $9.96M | $25.03M | $13.02M | $8.43M |
| Short-term debt | — | $1.50M | $5.85M | — | — |
| Long-term debt | $708,000 | $5.17M | $8.06M | $3.91M | — |
| Total debt | $708,000 | $6.67M | $13.91M | $3.91M | — |
| Total liabilities | $8.53M | $17.66M | $35.91M | $18.68M | $9.88M |
| Shareholders' equity | $15.76M | $4.01M | -$8.41M | $95.97M | $66.07M |
| Net debt | -$6.44M | $2.24M | $11.85M | $889,000 | — |
| Shares outstanding | 391 | 2,285 | 20,313 | 14.35M | 162.87M |
| Cash flow statement | |||||
| Operating cash flow | -$7.72M | -$14.35M | -$54.99M | -$51.71M | -$22.84M |
| Capital expenditure | $61,000 | $141,000 | $4.66M | $3.66M | $745,000 |
| Free cash flow | -$7.78M | -$14.49M | -$59.64M | -$55.37M | -$23.58M |
| Investing cash flow | -$505,000 | -$139,000 | $16.82M | $22.58M | -$27.73M |
| Financing cash flow | $10.96M | $16.85M | $37.21M | $30.82M | $50.88M |
| Depreciation & amortization | $479,000 | $585,000 | $852,000 | $673,000 | $1.25M |
| Stock-based compensation | $421,000 | $380,000 | $2.68M | $5.49M | $3.98M |
Free plan shows the latest 5 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.